SAM Tsz Wing Sara, is the Chief Technology Officer at InnoCellular (a subsidiary of Applitech Biological Technology Co., Ltd), a pioneering cell culture media start-up spun off from Agency for Science, Technology and Research (A*STAR), Singapore. InnoCellular specializes in delivering high-quality media for cell culture, enabling scalable advancements in cell therapy.
Sara earned her PhD from the National University of Singapore (NUS) with an A*STAR scholarship, focusing her research on induced pluripotent stem cell (iPSC)-derived erythroid cell differentiation and media formulation. With her expertise in stem cell, Sara drives innovation in developing cost-effective media tailored to meet the needs of researchers and clinicians. InnoCellular has also joined forces with Applitech to deliver scalable solutions for cell therapy, combining advanced media development with bioreactor technologies to optimize and streamline therapeutic manufacturing processes.
THE ROAD TO SCALABLE MANUFACTURING: CHALLENGES AND INNOVATIONS
Thursday, June 12, 2025
4:40 PM – 4:55 PM HK Time